Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University of Chicago
M.D. Anderson Cancer Center
Peking Union Medical College Hospital